To include your compound in the COVID-19 Resource Center, submit it here.

ThGRF 1-44: Began Phase II study

TH said it will begin a second Phase II trial of ThGRF 1-44 in

Read the full 149 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE